NCT04743323

Brief Summary

The Purpose of this study is to investigate changes in alcohol consumption in the period leading up to the onset of pancreatitis and compare that to levels of drinking during asymptomatic periods.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 8, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

August 31, 2023

Status Verified

August 1, 2023

Enrollment Period

3.6 years

First QC Date

February 4, 2021

Last Update Submit

August 29, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Alcohol Consumption

    Compare alcohol consumption prior to an attack of Acute Pancreatitis to that during an asymptomatic control period. Alcohol consumption will be measured by a 48-hour recall questionnaire, and timeline follow-back instrument.

    Between 5-26 weeks

Study Arms (1)

Study Participants

Participants will be recruited whilst hospitalized for an acute episode of pancreatitis. They will be interviewed about their health behaviors including alcohol consumption during the two weeks immediately preceding the onset of pancreatitis. Blood and urine bio-specimens will be collected at this time. Following discharge from hospital (5-26 weeks) the same participant will be interviewed again during an asymptomatic control period and blood and urine bio-specimens will be collected. This study will compare the participant's exposure immediately preceding the onset of pancreatitis to that of an asymptomatic control period from the same participant. Participants will be followed for 24 months via review of their medical records every 6 months to assess any recurrent disease or progression of disease.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults that consume alcohol who are hospitalized for acute pancreatitis.

You may qualify if:

  • Aged 18-75 years at the time of eligibility assessment
  • Currently hospitalized with Acute Pancreatitis (AP) per Revised Atlanta Classification, which requires two of the following evidence of pancreatitis:
  • Abdominal pain consistent with AP (acute onset of a persistent, severe, epigastric pain often radiating to the back)
  • Serum lipase activity (or amylase activity) at least three times greater than the upper limit of normal
  • Characteristic findings of AP on computed tomography (CT), magnetic resonance imaging (MRI) or transabdominal ultrasonography
  • Alcohol Use Disorders Identification Test Consumption (AUDIT-C) alcohol consumption score of ≥3

You may not qualify if:

  • Pancreatitis presumed to be related to: gallstones, medication, trauma, autoimmune pancreatitis, post-ERCP pancreatitis, pancreatic ductal adenocarcinoma, suspected cystic neoplasm, neuroendocrine tumors, and other uncommon tumors.
  • Chronic pancreatitis with calcification(s).
  • Pancreatic cancer or pancreatic metastasis from other malignancies.
  • History of pancreas transplant or pancreatectomy
  • Current medical or psychiatric illnesses that in the investigator's opinion would compromise their ability to tolerate study procedures or participate in longitudinal follow up.
  • Currently incarcerated.
  • Known current pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University of Southern California

Los Angeles, California, 90033, United States

Location

Cedars-Sinai Medical Center

Los Angeles, California, 90034, United States

Location

Veterans Affairs Greater Los Angeles Healthcare System

Los Angeles, California, 90034, United States

Location

Ohio State University

Columbus, Ohio, 43210, United States

Location

University of Pittsburg

Pittsburgh, Pennsylvania, 15260, United States

Location

Related Publications (3)

  • Cherpitel CJ, Ye Y, Bond J, Borges G, Macdonald S, Stockwell T, Room R, Sovinova H, Marais S, Giesbrecht N. Validity of self-reported drinking before injury compared with a physiological measure: cross-national analysis of emergency-department data from 16 countries. J Stud Alcohol Drugs. 2007 Mar;68(2):296-302. doi: 10.15288/jsad.2007.68.296.

    PMID: 17286349BACKGROUND
  • Jeon CY, Papachristou GI, Pisegna JR, Pendergast FJ, Lin YC, Cherpitel CJ, Ye Y, Pandol SJ, Yadav D. A Case-CrossovEr study deSign to inform tailored interventions to prevent disease progression in Acute Pancreatitis (ACCESS-AP) - study design and population. Pancreatology. 2021 Oct;21(7):1231-1236. doi: 10.1016/j.pan.2021.06.007. Epub 2021 Jun 24.

    PMID: 34229971BACKGROUND
  • Jeon CY, Adeniran E, Stewart C, Papachristou GI, Pisegna JR, Kuc AA, Buxbaum JL, Pandol SJ, Yadav D. Female patients delay seeking medical care with alcohol-associated acute pancreatitis. Pancreatology. 2023 Nov;23(7):761-766. doi: 10.1016/j.pan.2023.08.001. Epub 2023 Aug 5.

MeSH Terms

Conditions

PancreatitisAlcohol DrinkingHealth Behavior

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesDrinking BehaviorBehavior

Study Officials

  • Christie Y Jeon, ScD

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

February 4, 2021

First Posted

February 8, 2021

Study Start

June 1, 2020

Primary Completion

December 31, 2023

Study Completion

June 1, 2024

Last Updated

August 31, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations